Loading...
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-...
Na minha lista:
| Udgivet i: | Mol Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956614/ https://ncbi.nlm.nih.gov/pubmed/29769134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0840-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|